This document provides an overview of toxicology and the problems evaluated by toxicologists. It discusses Kurt Kleinschmidt's role as the division chief and program director of medical toxicology at UTSW Medical Center. Some of the key issues toxicologists deal with include drug overdoses, hazardous chemical exposures, envenomations, and food-borne toxins. The document also summarizes the certification process for medical toxicologists and covers common toxidromes like anticholinergic, cholinergic, opioid, and serotonergic syndromes.
This document provides an overview of toxicology and related topics. It defines toxicology as the study of poisons and their sources, properties, mechanisms of toxicity, toxic effects, detection, clinical manifestations, and management. It describes different types of toxic agents and mechanisms of toxicity. It also discusses factors that affect the action of poisons, including dose, route of exposure, and individual susceptibility. Analytical toxicology methods for qualitative and quantitative analysis are summarized, including chromatography techniques and immunoassays. The key steps and factors in the mechanism of toxicity, from delivery to the target site to repair or dysfunction, are outlined.
The document discusses various topics related to toxicology including:
- Absorption, distribution, metabolism and excretion of chemicals in the body
- Factors that affect absorption such as routes of entry and chemical properties
- Threshold doses and variability in individual susceptibility
- Acute and chronic effects of toxins
- Carcinogens and mutagens and their classification
- Dose-response relationships and metrics like LD50
- Toxicity testing methods including the Ames test
A 17-year-old man was brought to the hospital drunk, depressed, and having taken pills and alcohol after failing exams. He was treated with IV fluids, monitored until sober, and discharged home with psychiatric support. Three days later he returned with jaundice, leading to the diagnosis of paracetamol poisoning.
Anti seizure and rescue medications.updated 8.7.2014Cleveland Clinic
This document discusses anti-seizure medications. It begins by defining antiepileptic drugs as medications that are used to treat epilepsy and decrease the frequency and severity of seizures. It then discusses the historical development of anti-seizure medications, how doctors select which medications to treat different types of seizures, common side effects of the medications including both acute and long-term effects, special considerations for different patient populations, drug interactions, and seizure rescue medications.
This document discusses chemistry panels and provides case studies. It describes common chemistry panels including their components and purposes. Normal ranges for various values are provided. Two case studies are then presented: a 36-year-old female presenting with altered mental status and seizures, and a 69-year-old female with increasing dyspnea and abdominal pain. Differentials and appropriate tests are discussed for each case.
This document provides information on chemistry panels, including common names, components, and reference ranges for various tests. It also includes two case studies. The first case involves a 36-year-old female presenting with altered mental status and seizures who is found to have malnutrition and liver dysfunction. The second case involves a 69-year-old female with COPD and heart failure presenting with abdominal pain and swelling along with enlarged organs and ascites.
This document provides information on chemistry panels, including common names, components, and reference ranges for various tests. It also discusses two patient case studies. The first case involves a 36-year-old female presenting with altered mental status and seizures who is found to have severe malnutrition and liver dysfunction from alcoholism. The second case describes a 69-year-old woman with COPD and heart failure presenting with abdominal pain and swelling along with weight loss who is found to have organomegaly and ascites.
A 55-year-old male presented with jaundice, decreased urination, and swelling of the body for 1 month. He has a history of alcoholism and smoking for 3 years. Laboratory tests revealed elevated bilirubin, liver enzymes, and signs of portal hypertension. He was diagnosed with alcoholic liver disease. Treatment included medications to protect the liver, manage complications, and lifestyle changes like abstaining from alcohol. Due to his condition, consultation with nutrition, gastroenterology, nephrology, neurology, and infectious disease services was recommended. Immunization against common liver pathogens and lifestyle modifications were also advised to prevent further damage and support recovery.
This document provides an overview of toxicology and related topics. It defines toxicology as the study of poisons and their sources, properties, mechanisms of toxicity, toxic effects, detection, clinical manifestations, and management. It describes different types of toxic agents and mechanisms of toxicity. It also discusses factors that affect the action of poisons, including dose, route of exposure, and individual susceptibility. Analytical toxicology methods for qualitative and quantitative analysis are summarized, including chromatography techniques and immunoassays. The key steps and factors in the mechanism of toxicity, from delivery to the target site to repair or dysfunction, are outlined.
The document discusses various topics related to toxicology including:
- Absorption, distribution, metabolism and excretion of chemicals in the body
- Factors that affect absorption such as routes of entry and chemical properties
- Threshold doses and variability in individual susceptibility
- Acute and chronic effects of toxins
- Carcinogens and mutagens and their classification
- Dose-response relationships and metrics like LD50
- Toxicity testing methods including the Ames test
A 17-year-old man was brought to the hospital drunk, depressed, and having taken pills and alcohol after failing exams. He was treated with IV fluids, monitored until sober, and discharged home with psychiatric support. Three days later he returned with jaundice, leading to the diagnosis of paracetamol poisoning.
Anti seizure and rescue medications.updated 8.7.2014Cleveland Clinic
This document discusses anti-seizure medications. It begins by defining antiepileptic drugs as medications that are used to treat epilepsy and decrease the frequency and severity of seizures. It then discusses the historical development of anti-seizure medications, how doctors select which medications to treat different types of seizures, common side effects of the medications including both acute and long-term effects, special considerations for different patient populations, drug interactions, and seizure rescue medications.
This document discusses chemistry panels and provides case studies. It describes common chemistry panels including their components and purposes. Normal ranges for various values are provided. Two case studies are then presented: a 36-year-old female presenting with altered mental status and seizures, and a 69-year-old female with increasing dyspnea and abdominal pain. Differentials and appropriate tests are discussed for each case.
This document provides information on chemistry panels, including common names, components, and reference ranges for various tests. It also includes two case studies. The first case involves a 36-year-old female presenting with altered mental status and seizures who is found to have malnutrition and liver dysfunction. The second case involves a 69-year-old female with COPD and heart failure presenting with abdominal pain and swelling along with enlarged organs and ascites.
This document provides information on chemistry panels, including common names, components, and reference ranges for various tests. It also discusses two patient case studies. The first case involves a 36-year-old female presenting with altered mental status and seizures who is found to have severe malnutrition and liver dysfunction from alcoholism. The second case describes a 69-year-old woman with COPD and heart failure presenting with abdominal pain and swelling along with weight loss who is found to have organomegaly and ascites.
A 55-year-old male presented with jaundice, decreased urination, and swelling of the body for 1 month. He has a history of alcoholism and smoking for 3 years. Laboratory tests revealed elevated bilirubin, liver enzymes, and signs of portal hypertension. He was diagnosed with alcoholic liver disease. Treatment included medications to protect the liver, manage complications, and lifestyle changes like abstaining from alcohol. Due to his condition, consultation with nutrition, gastroenterology, nephrology, neurology, and infectious disease services was recommended. Immunization against common liver pathogens and lifestyle modifications were also advised to prevent further damage and support recovery.
This document discusses vitamins and vitamin deficiencies. It provides details on 13 vitamins, including 8 B vitamins. Key points include:
- Vitamins are chemically unrelated substances that are needed in small amounts for metabolism and are not made by the body, with the exceptions of vitamins D and K.
- Deficiencies of certain vitamins can cause diseases like beriberi (vitamin B1), pellagra (vitamin B3), and scurvy (vitamin C).
- The document focuses on specific B vitamins including their roles, sources, deficiencies, and related diseases. Thiamine (B1) deficiency can cause beriberi, and niacin (B3) deficiency can cause pell
Procedural Sedation and Excited Delirium for the EDDavid Marcus
Combined slideset reviewing ED Procedural Sedation and Analgesia as well as the emergent care of patients with Excited Delirium. Originally delivered for EM residents in Nov 2019
This document discusses various types of drug and chemical poisonings. It covers the classification, incidence, drugs commonly involved, clinical presentations, investigations, management principles, and specific treatments for paracetamol, salicylates, and NSAIDs. The key points are: accidental poisoning is most common in children under 5, deliberate self-poisoning is common in adults over 15, and management involves supportive care, preventing further absorption, enhancing elimination, and specific antidotes/treatments depending on the toxin. N-acetylcysteine is the antidote for paracetamol overdose, sodium bicarbonate and hemodialysis are used to treat salicylate poisoning, and activated charcoal and
Clinical Reasoning: How Some Doctors Think and the Rest of Us Try ToSHMLive
An 83-year-old woman presented with a 1-year history of gastroparesis of unclear etiology, manifesting as bloating, vomiting, and failure to thrive. Tests confirmed delayed gastric emptying. She also had a history of breast cancer, congestive heart failure, and was taking metoclopramide. On presentation, she appeared frail and had distended abdomen, hypoactive bowel sounds, and lower extremity edema. Labs showed mild anemia, hypoalbuminemia, and 3.5g protein in 24-hour urine. The patient's gastroparesis and generalized decline require further evaluation and management.
The unconscious patient and patient with altered consciousness- medicalbhawesh rai
This document provides guidance on evaluating and managing an unconscious patient. It outlines steps to take a history, check vital signs, perform analyses based on common causes, and provide general management. Key points include taking a history from the patient or bystander; checking respiration, pulse, blood pressure, temperature and blood sugar; considering common conditions like alcohol/drug abuse, hypertension, diabetes, fever or epilepsy; and managing the patient's airway, breathing, circulation and blood sugar. Specific conditions discussed include hepatic encephalopathy, Wernicke's encephalopathy, diabetic ketoacidosis, hypoglycemia, acute liver failure, meningitis, encephalitis, cerebral malaria, stroke/TIA, hypertensive
This document discusses pre-eclampsia, a disease of pregnancy characterized by high blood pressure (BP 140/90 or more) developing after 20 weeks of gestation in a previously normotensive woman. Pre-eclampsia can progress to eclampsia, which involves seizures. Risk factors include primigravida, age, past history, and socioeconomic status. Symptoms may include headache, visual disturbances, epigastric pain, and edema. Diagnosis is based on elevated blood pressure readings taken twice over six hours. Management involves delivering the baby to terminate the pregnancy, administering magnesium sulfate to prevent seizures, and controlling blood pressure. Complications can include maternal and fetal consequences such as renal failure, stroke,
1. Volume depletion occurs when fluid loss exceeds intake, leading to extracellular fluid loss. Common causes include vomiting, diarrhea, burns, and diuretic use.
2. Symptoms of volume depletion include lethargy, thirst, muscle cramps, dizziness, and generalized weakness. Physical exam may reveal low blood pressure that drops further upon standing, increased heart rate, decreased skin turgor and dry mucous membranes.
3. Treatment involves intravenous fluid replacement with isotonic fluids like normal saline. Fluid status is monitored by checking orthostatic blood pressures and urine output. Electrolyte abnormalities are treated as needed.
Cardiac glycosides like digoxin are used to treat heart failure. They work by inhibiting the sodium-potassium ATPase pump, increasing intracellular calcium levels and improving cardiac contractility. At therapeutic doses, they have positive inotropic and chronotropic effects as well as autonomic effects like sensitizing baroreceptors. At toxic doses, they can cause arrhythmias by prolonging action potentials and causing delayed afterdepolarizations due to calcium overload. They are beneficial in both acute and chronic heart failure by improving cardiac function and efficiency without increasing oxygen demand.
Prof. Mridul Panditrao's Peri-operative Management of Jehovah's Witness Patient Prof. Mridul Panditrao
This document describes the peri-operative management of a Jehovah's Witness patient requiring an emergency exploratory laparotomy who refused blood transfusion. It presents a case report of a 65-year-old male who underwent surgery under general anesthesia. Special consent was obtained for no blood transfusion. Intraoperatively, blood loss was replaced with crystalloids and the colloid Tetrastarch (Voluven) to maintain cardiovascular stability given the patient's anemia. The patient had an uneventful recovery without blood transfusion, demonstrating that surgery can be safely performed in Jehovah's Witness patients refusing transfusion through careful pre-operative optimization and use of alternatives to blood loss replacement like collo
Preeclampsia is a pregnancy complication defined by high blood pressure and excess protein in the urine after 20 weeks of gestation. It can range from mild to severe, with severe preeclampsia presenting additional symptoms such as headaches, visual disturbances, and edema. Left untreated, preeclampsia poses risks to both mother and baby. Nursing management involves monitoring for complications, providing prescribed treatments which may include bed rest, magnesium sulfate, and antihypertensives, instituting seizure precautions, and addressing emotional needs.
Vitamins are essential nutrients that must be obtained through diet as they cannot be produced by the body, with a few exceptions. They are categorized as either water-soluble or fat-soluble. Deficiencies can cause various diseases like beriberi, pellagra, and scurvy. The document discusses several B vitamins in detail, including their roles, sources, deficiencies, and treatment. Thiamine deficiency can cause beriberi while niacin deficiency results in pellagra. Maintaining a balanced diet is important to prevent vitamin deficiencies.
This document provides guidance on choosing psychotropic medications for patients with medical problems. It discusses general principles and considerations for conditions like pregnancy, breastfeeding, old age, cardiovascular disease, lung disease, liver/renal impairment, diabetes, epilepsy, surgery, and glaucoma. Lower risk drug options are suggested for each condition. Examples of case presentations are also provided. The key points are: carefully consider each patient's medical issues and choose drugs less likely to interact negatively or exacerbate conditions; start low and slow; discuss potential drug-disease interactions with relevant specialists; and educate patients on risks.
1040122 oab diagnosis, management and current trend of therapyAlex Chen
This document discusses overactive bladder (OAB). It defines OAB as a symptom syndrome characterized by urgency, with or without urge incontinence, usually accompanied by frequency and nocturia. The prevalence of OAB is estimated to be around 16-17% globally. Common causes include problems with the pelvic floor muscles, nervous system issues, and other factors. OAB can negatively impact quality of life by limiting physical, sexual, occupational, social, domestic, and psychological activities. Treatment involves behavioral modifications, pharmacotherapy such as anticholinergic medications, and in some cases neuromodulation procedures or surgery.
1040122 oab diagnosis, management and current trend of therapyAlex Chen
This document discusses overactive bladder (OAB). It defines OAB as a symptom syndrome characterized by urgency, with or without urge incontinence, usually accompanied by frequency and nocturia. The prevalence of OAB is estimated to be around 16-17% globally. Common causes include problems with the pelvic floor muscles, nervous system issues, and other factors. OAB can negatively impact quality of life by limiting physical, sexual, occupational, social, domestic, and psychological activities. Treatment involves behavioral modifications, pharmacotherapy such as anticholinergic medications, and in some cases neuromodulation procedures or surgery.
This document provides information on various drugs used to induce vomiting (emetics) or prevent vomiting (anti-emetics). It discusses the uses of ipecac syrup and other emetics to induce vomiting in poisonings when indicated. It also covers different classes of anti-emetic drugs like antihistamines, anticholinergics, dopamine antagonists, benzodiazepines, serotonin antagonists and their mechanisms of action and side effects. Common anti-emetic drugs discussed include promethazine, scopolamine, droperidol, lorazepam, ondansetron and metoclopramide. The document also summarizes purgatives and laxatives used to
Pediatric transport involves stabilizing critically ill children and continuing critical care therapies en route. The transport team conducts a thorough assessment using standardized approaches like the pediatric assessment triangle and ABCDE model. Key priorities are stabilizing the airway, breathing, circulation, neurological status and managing pain and anxiety. Important equipment includes ventilators, infusion pumps, suction, monitoring and temperature regulation devices designed for portability and reliability during transport. Proper preparation is essential to minimize risks and continue care seamlessly between facilities.
The document discusses iron and lithium toxicity. It provides details on normal iron levels, signs of iron toxicity, phases of iron poisoning, and treatment including whole bowel irrigation and deferoxamine. It also discusses lithium toxicity, contributing factors, and appropriate management including IV fluids and hemodialysis.
An approach to a case of poisoning (MBBS)Homendra Sah
A 35-year-old male presented to the emergency room with tremors, shortness of breath, nausea, and vomiting after ingesting an unknown substance. The document provides guidance on evaluating and managing poisoning cases, including obtaining a thorough history, conducting a physical exam, ordering relevant investigations, providing supportive care and monitoring, considering decontamination procedures, enhancing elimination, and administering antidotes as needed. Specific symptoms and treatments are discussed for organophosphorus, paracetamol, aluminum phosphide, and zinc phosphide poisonings.
Liver transplantation - Whom to transplant and when?hr77
- Liver transplantation should be considered when patients with cirrhosis experience complications such as ascites, variceal bleeding, or hepatorenal syndrome, as these indicate significantly impaired survival without transplantation.
- Patients are generally referred for transplant evaluation when their Child-Pugh score reaches B or higher, or at the onset of their first decompensation event.
- The goal of transplantation is to prolong survival, so it should be performed when a patient's survival is expected to be greater with a transplant than without.
The document discusses antiemetics, which are drugs used to treat nausea and vomiting. It defines nausea, vomiting, and antiemetic agents. It describes the vomiting center and chemoreceptor trigger zone in the brain which stimulate vomiting once activated. It explains the different mechanisms of action that various antiemetics use to block vomiting pathways, such as blocking acetylcholine, histamine H1 receptors, dopamine receptors, serotonin receptors, and cannabinoid receptors. Finally, it reviews the indications for different classes of antiemetics in treating conditions like chemotherapy-induced nausea and vomiting, postoperative nausea, and motion sickness.
This document provides a summary of articles across various medical specialties discussed in the April 2015 edition of the UTSW Journal Watch. In the Hepatology section, an article is summarized that finds corticosteroids may be safely used in patients with severe alcoholic hepatitis who present with an upper GI bleed after bleeding is controlled. In Pulmonary/Critical Care, a summary is provided of a trial finding no difference in mortality between early goal-directed therapy and usual care for treating septic shock. The study suggests protocols for goals of care are less important than early antibiotics and fluids. In Nephrology, a meta-analysis summary indicates preoperative use of renin-angiotensin system inhibitors may be linked to
The CT chest scan showed mosaic attenuation with air-trapping as well as an increase in size of a non-calcified lingular nodule and other scattered nodules.
This document discusses vitamins and vitamin deficiencies. It provides details on 13 vitamins, including 8 B vitamins. Key points include:
- Vitamins are chemically unrelated substances that are needed in small amounts for metabolism and are not made by the body, with the exceptions of vitamins D and K.
- Deficiencies of certain vitamins can cause diseases like beriberi (vitamin B1), pellagra (vitamin B3), and scurvy (vitamin C).
- The document focuses on specific B vitamins including their roles, sources, deficiencies, and related diseases. Thiamine (B1) deficiency can cause beriberi, and niacin (B3) deficiency can cause pell
Procedural Sedation and Excited Delirium for the EDDavid Marcus
Combined slideset reviewing ED Procedural Sedation and Analgesia as well as the emergent care of patients with Excited Delirium. Originally delivered for EM residents in Nov 2019
This document discusses various types of drug and chemical poisonings. It covers the classification, incidence, drugs commonly involved, clinical presentations, investigations, management principles, and specific treatments for paracetamol, salicylates, and NSAIDs. The key points are: accidental poisoning is most common in children under 5, deliberate self-poisoning is common in adults over 15, and management involves supportive care, preventing further absorption, enhancing elimination, and specific antidotes/treatments depending on the toxin. N-acetylcysteine is the antidote for paracetamol overdose, sodium bicarbonate and hemodialysis are used to treat salicylate poisoning, and activated charcoal and
Clinical Reasoning: How Some Doctors Think and the Rest of Us Try ToSHMLive
An 83-year-old woman presented with a 1-year history of gastroparesis of unclear etiology, manifesting as bloating, vomiting, and failure to thrive. Tests confirmed delayed gastric emptying. She also had a history of breast cancer, congestive heart failure, and was taking metoclopramide. On presentation, she appeared frail and had distended abdomen, hypoactive bowel sounds, and lower extremity edema. Labs showed mild anemia, hypoalbuminemia, and 3.5g protein in 24-hour urine. The patient's gastroparesis and generalized decline require further evaluation and management.
The unconscious patient and patient with altered consciousness- medicalbhawesh rai
This document provides guidance on evaluating and managing an unconscious patient. It outlines steps to take a history, check vital signs, perform analyses based on common causes, and provide general management. Key points include taking a history from the patient or bystander; checking respiration, pulse, blood pressure, temperature and blood sugar; considering common conditions like alcohol/drug abuse, hypertension, diabetes, fever or epilepsy; and managing the patient's airway, breathing, circulation and blood sugar. Specific conditions discussed include hepatic encephalopathy, Wernicke's encephalopathy, diabetic ketoacidosis, hypoglycemia, acute liver failure, meningitis, encephalitis, cerebral malaria, stroke/TIA, hypertensive
This document discusses pre-eclampsia, a disease of pregnancy characterized by high blood pressure (BP 140/90 or more) developing after 20 weeks of gestation in a previously normotensive woman. Pre-eclampsia can progress to eclampsia, which involves seizures. Risk factors include primigravida, age, past history, and socioeconomic status. Symptoms may include headache, visual disturbances, epigastric pain, and edema. Diagnosis is based on elevated blood pressure readings taken twice over six hours. Management involves delivering the baby to terminate the pregnancy, administering magnesium sulfate to prevent seizures, and controlling blood pressure. Complications can include maternal and fetal consequences such as renal failure, stroke,
1. Volume depletion occurs when fluid loss exceeds intake, leading to extracellular fluid loss. Common causes include vomiting, diarrhea, burns, and diuretic use.
2. Symptoms of volume depletion include lethargy, thirst, muscle cramps, dizziness, and generalized weakness. Physical exam may reveal low blood pressure that drops further upon standing, increased heart rate, decreased skin turgor and dry mucous membranes.
3. Treatment involves intravenous fluid replacement with isotonic fluids like normal saline. Fluid status is monitored by checking orthostatic blood pressures and urine output. Electrolyte abnormalities are treated as needed.
Cardiac glycosides like digoxin are used to treat heart failure. They work by inhibiting the sodium-potassium ATPase pump, increasing intracellular calcium levels and improving cardiac contractility. At therapeutic doses, they have positive inotropic and chronotropic effects as well as autonomic effects like sensitizing baroreceptors. At toxic doses, they can cause arrhythmias by prolonging action potentials and causing delayed afterdepolarizations due to calcium overload. They are beneficial in both acute and chronic heart failure by improving cardiac function and efficiency without increasing oxygen demand.
Prof. Mridul Panditrao's Peri-operative Management of Jehovah's Witness Patient Prof. Mridul Panditrao
This document describes the peri-operative management of a Jehovah's Witness patient requiring an emergency exploratory laparotomy who refused blood transfusion. It presents a case report of a 65-year-old male who underwent surgery under general anesthesia. Special consent was obtained for no blood transfusion. Intraoperatively, blood loss was replaced with crystalloids and the colloid Tetrastarch (Voluven) to maintain cardiovascular stability given the patient's anemia. The patient had an uneventful recovery without blood transfusion, demonstrating that surgery can be safely performed in Jehovah's Witness patients refusing transfusion through careful pre-operative optimization and use of alternatives to blood loss replacement like collo
Preeclampsia is a pregnancy complication defined by high blood pressure and excess protein in the urine after 20 weeks of gestation. It can range from mild to severe, with severe preeclampsia presenting additional symptoms such as headaches, visual disturbances, and edema. Left untreated, preeclampsia poses risks to both mother and baby. Nursing management involves monitoring for complications, providing prescribed treatments which may include bed rest, magnesium sulfate, and antihypertensives, instituting seizure precautions, and addressing emotional needs.
Vitamins are essential nutrients that must be obtained through diet as they cannot be produced by the body, with a few exceptions. They are categorized as either water-soluble or fat-soluble. Deficiencies can cause various diseases like beriberi, pellagra, and scurvy. The document discusses several B vitamins in detail, including their roles, sources, deficiencies, and treatment. Thiamine deficiency can cause beriberi while niacin deficiency results in pellagra. Maintaining a balanced diet is important to prevent vitamin deficiencies.
This document provides guidance on choosing psychotropic medications for patients with medical problems. It discusses general principles and considerations for conditions like pregnancy, breastfeeding, old age, cardiovascular disease, lung disease, liver/renal impairment, diabetes, epilepsy, surgery, and glaucoma. Lower risk drug options are suggested for each condition. Examples of case presentations are also provided. The key points are: carefully consider each patient's medical issues and choose drugs less likely to interact negatively or exacerbate conditions; start low and slow; discuss potential drug-disease interactions with relevant specialists; and educate patients on risks.
1040122 oab diagnosis, management and current trend of therapyAlex Chen
This document discusses overactive bladder (OAB). It defines OAB as a symptom syndrome characterized by urgency, with or without urge incontinence, usually accompanied by frequency and nocturia. The prevalence of OAB is estimated to be around 16-17% globally. Common causes include problems with the pelvic floor muscles, nervous system issues, and other factors. OAB can negatively impact quality of life by limiting physical, sexual, occupational, social, domestic, and psychological activities. Treatment involves behavioral modifications, pharmacotherapy such as anticholinergic medications, and in some cases neuromodulation procedures or surgery.
1040122 oab diagnosis, management and current trend of therapyAlex Chen
This document discusses overactive bladder (OAB). It defines OAB as a symptom syndrome characterized by urgency, with or without urge incontinence, usually accompanied by frequency and nocturia. The prevalence of OAB is estimated to be around 16-17% globally. Common causes include problems with the pelvic floor muscles, nervous system issues, and other factors. OAB can negatively impact quality of life by limiting physical, sexual, occupational, social, domestic, and psychological activities. Treatment involves behavioral modifications, pharmacotherapy such as anticholinergic medications, and in some cases neuromodulation procedures or surgery.
This document provides information on various drugs used to induce vomiting (emetics) or prevent vomiting (anti-emetics). It discusses the uses of ipecac syrup and other emetics to induce vomiting in poisonings when indicated. It also covers different classes of anti-emetic drugs like antihistamines, anticholinergics, dopamine antagonists, benzodiazepines, serotonin antagonists and their mechanisms of action and side effects. Common anti-emetic drugs discussed include promethazine, scopolamine, droperidol, lorazepam, ondansetron and metoclopramide. The document also summarizes purgatives and laxatives used to
Pediatric transport involves stabilizing critically ill children and continuing critical care therapies en route. The transport team conducts a thorough assessment using standardized approaches like the pediatric assessment triangle and ABCDE model. Key priorities are stabilizing the airway, breathing, circulation, neurological status and managing pain and anxiety. Important equipment includes ventilators, infusion pumps, suction, monitoring and temperature regulation devices designed for portability and reliability during transport. Proper preparation is essential to minimize risks and continue care seamlessly between facilities.
The document discusses iron and lithium toxicity. It provides details on normal iron levels, signs of iron toxicity, phases of iron poisoning, and treatment including whole bowel irrigation and deferoxamine. It also discusses lithium toxicity, contributing factors, and appropriate management including IV fluids and hemodialysis.
An approach to a case of poisoning (MBBS)Homendra Sah
A 35-year-old male presented to the emergency room with tremors, shortness of breath, nausea, and vomiting after ingesting an unknown substance. The document provides guidance on evaluating and managing poisoning cases, including obtaining a thorough history, conducting a physical exam, ordering relevant investigations, providing supportive care and monitoring, considering decontamination procedures, enhancing elimination, and administering antidotes as needed. Specific symptoms and treatments are discussed for organophosphorus, paracetamol, aluminum phosphide, and zinc phosphide poisonings.
Liver transplantation - Whom to transplant and when?hr77
- Liver transplantation should be considered when patients with cirrhosis experience complications such as ascites, variceal bleeding, or hepatorenal syndrome, as these indicate significantly impaired survival without transplantation.
- Patients are generally referred for transplant evaluation when their Child-Pugh score reaches B or higher, or at the onset of their first decompensation event.
- The goal of transplantation is to prolong survival, so it should be performed when a patient's survival is expected to be greater with a transplant than without.
The document discusses antiemetics, which are drugs used to treat nausea and vomiting. It defines nausea, vomiting, and antiemetic agents. It describes the vomiting center and chemoreceptor trigger zone in the brain which stimulate vomiting once activated. It explains the different mechanisms of action that various antiemetics use to block vomiting pathways, such as blocking acetylcholine, histamine H1 receptors, dopamine receptors, serotonin receptors, and cannabinoid receptors. Finally, it reviews the indications for different classes of antiemetics in treating conditions like chemotherapy-induced nausea and vomiting, postoperative nausea, and motion sickness.
Similar to Noon conference: Intro to Toxicology (20)
This document provides a summary of articles across various medical specialties discussed in the April 2015 edition of the UTSW Journal Watch. In the Hepatology section, an article is summarized that finds corticosteroids may be safely used in patients with severe alcoholic hepatitis who present with an upper GI bleed after bleeding is controlled. In Pulmonary/Critical Care, a summary is provided of a trial finding no difference in mortality between early goal-directed therapy and usual care for treating septic shock. The study suggests protocols for goals of care are less important than early antibiotics and fluids. In Nephrology, a meta-analysis summary indicates preoperative use of renin-angiotensin system inhibitors may be linked to
The CT chest scan showed mosaic attenuation with air-trapping as well as an increase in size of a non-calcified lingular nodule and other scattered nodules.
This document summarizes guidelines for screening and treatment related to gynecologic health in menopausal women. It discusses recommendations and risks for cervical and breast cancer screening, as well as guidelines for and risks of hormone replacement therapy. It also reports on non-hormonal options for treating post-menopausal symptoms like hot flashes. The document provides this information through a series of clinical vignettes and recommendations based on evidence from sources like the USPSTF.
This document provides guidance on identifying and managing clinically significant depression for internists. It outlines how to take a thorough history to assess for depression, safety risks, substance use, bipolarity and psychosis. Common mimics of depression like delirium, substance withdrawal and medical condition-related depression are reviewed. First-line antidepressant medications are SSRIs, SNRIs, bupropion and mirtazapine. The document describes strategies for patients who do not improve on initial treatment, such as switching or augmenting medications. Non-pharmacological approaches like exercise and social support are also encouraged.
This document discusses the evaluation and treatment of low back pain. It notes that low back pain is very common, affecting 90% of people and costing $40 billion annually. For acute low back pain, the short answer is to leave patients alone and for chronic pain, recommend back classes and functional rehabilitation. Red flags to evaluate for include cancer, infection, or neurological deficits. The goal is to distinguish the 95% with simple back pain from the 5% with serious underlying issues. Conservative treatment is usually sufficient, with opioids not recommended for chronic pain due to lack of evidence of long-term benefit and risk of harm.
This document discusses the evaluation and treatment of low back pain. It notes that low back pain is very common, affecting 90% of people and costing $40 billion annually. For acute low back pain, the short answer is to leave patients alone and for chronic pain, recommend back classes and functional rehabilitation. Red flags to evaluate for include cancer, infection, or neurological deficits. The goal is to distinguish the 95% with simple back pain from the 5% with a serious underlying problem. Conservative treatment including education, exercise, and over-the-counter medications is usually sufficient. Opioids are not recommended for chronic back pain due to lack of evidence of long-term benefit and risk of harm.
This document summarizes a presentation on atypical hemolytic uremic syndrome (aHUS). The key points are:
1) Atypical HUS is caused by dysregulation of the alternative complement pathway leading to thrombotic microangiopathy. There is often an underlying genetic predisposition that is triggered by stressors like pregnancy.
2) Treatment with plasma therapy and transplantation previously had limited success due to recurrent disease.
3) The monoclonal antibody eculizumab, a C5 inhibitor, is highly effective at treating and preventing recurrence of aHUS. However, the high cost of the medication presents barriers to treatment.
Mr. Lung is a 78-year-old man scheduled for a 4-hour L3-5 laminectomy and fusion who has severe COPD, diabetes, hypertension, and a 40 pack-year smoking history. He takes medications for his COPD and other conditions and is functionally independent but dyspneic with exertion. Preoperative evaluation shows he is at increased risk for postoperative pulmonary complications according to several risk prediction models. Recommendations are made for postoperative lung expansion techniques and monitoring to help mitigate his risks.
Based on the evidence presented in the document, the appropriate recommendation for Mrs. K would be a lifestyle intervention with a goal of 7% weight loss (Option B). The DPP trial demonstrated that lifestyle intervention, aimed at 7% weight loss through diet and exercise, reduced the risk of developing diabetes by 58% over 3 years compared to placebo. This lifestyle intervention was more effective than metformin alone in preventing diabetes.
1. The Diabetes Prevention Program (DPP) found that an intensive lifestyle intervention aimed at 7% weight loss was more effective than metformin or placebo at preventing diabetes in patients with prediabetes over 3 years, with a 58% reduction in relative risk.
2. For Mrs. K, an intensive lifestyle intervention targeting at least 7% weight loss would be the recommended first-line evidence-based approach based on the DPP findings.
3. After 1 year of lifestyle changes, Mrs. K had achieved 6% weight loss and normal fasting glucose and A1C levels, indicating response to treatment. However, 12 months later with 10 pounds regained, her glucose levels have
Community-acquired pneumonia (CAP) is a leading cause of death and hospitalization in the United States. Guidelines recommend using severity of illness scores like CURB-65 to determine appropriate site of care and empiric antibiotic therapy including β-lactams with macrolides or fluoroquinolones. Studies show guideline-concordant therapy improves outcomes. Procalcitonin levels may help determine duration of antibiotics, with lower levels associated with shorter treatment. Overall, clinicians should aim for 5-7 days of effective antibiotics guided by clinical and procalcitonin findings to optimize CAP treatment.
This document summarizes information on altitude physiology and acute illnesses that can occur at high altitude. It discusses how oxygen levels decrease with increasing altitude, leading to tissue hypoxia. It describes the body's acclimatization process through various pulmonary, cardiovascular, cerebrovascular, and hematologic adaptations. The most common high altitude illnesses are acute mountain sickness, high altitude cerebral edema, and high altitude pulmonary edema. The document provides details on risk factors, symptoms, treatments, and prevention strategies for each of these illnesses. It emphasizes the importance of gradual ascent and allowing time for acclimatization to reduce risks.
This document discusses complications that can arise in patients with cirrhosis, including portal hypertension, ascites, hepatic encephalopathy, and hepatorenal syndrome. It provides details on the pathophysiology, clinical presentation, diagnosis, and treatment of these complications. Specifically, it focuses on portal hypertension and the development of varices, describing the risks of variceal bleeding and approaches to prevention and management. It also covers ascites extensively, explaining how and why it develops in cirrhosis and its treatment with diuretics and sodium restriction.
This document provides an overview of various food intoxications, covering bacteria such as Staphylococcus aureus, Bacillus cereus, Clostridium perfringens, and toxins including ciguatera, scombroid, tetrodotoxin, and domoic acid from contaminated shellfish. It describes the organisms and toxins involved, foods commonly associated with poisoning, symptoms, mechanisms of toxicity, and treatments for each type of food intoxication.
This document summarizes key information about peptic ulcer disease and Helicobacter pylori (H. pylori). It discusses how H. pylori eradication benefits active gastric ulcer, past duodenal ulcer, and gastric MALT lymphoma. Proton pump inhibitors, sucralfate, and misoprostol are effective in decreasing NSAID-induced ulcers. H. pylori infection is associated with gastric adenocarcinoma through a sequence of events. Triple therapy is the preferred first line treatment for H. pylori, while quadruple therapy is used for retreatment. Risk of NSAID-induced ulcers increases with corticosteroid use, anticoagulant use,
March 192015talkforresidents final03232015 (1)katejohnpunag
This document provides an update on viral hepatitis and discusses two case studies. It begins by describing a 71-year-old male presenting with jaundice who is diagnosed with acute hepatitis A infection based on a reactive HAV IgM test. It then reviews hepatitis A virus and the diagnosis and management of acute hepatitis A. The second case discusses a 26-year-old male diagnosed with chronic hepatitis B infection based on positive HBsAg, anti-HBc IgM, and HBV DNA tests. The document concludes by discussing chronic hepatitis B infection and approved treatments.
This summary reviews a journal club discussion on two phase 3 clinical trials evaluating the efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis (IPF). The trials found that nintedanib significantly reduced the rate of decline in forced vital capacity (FVC) over 52 weeks compared to placebo. There was no consistent effect on time to first acute exacerbation or change in symptoms. Common side effects included diarrhea. While the study design was valid, questions remain regarding the clinical significance of the outcomes and relevance of factors like smoking status.
This document discusses the increasing use of therapeutic monoclonal antibodies in internal medicine. It provides examples of monoclonal antibodies used in various specialties like hematology/oncology, rheumatology, gastroenterology, and cardiology. The document outlines the historical development of monoclonal antibody technology from the 1890s to modern advances in recombinant DNA and transgenic mice that have allowed for humanized monoclonal antibodies. It notes both the benefits monoclonal antibodies have provided but also the issues of diminishing response, high costs, and sometimes unanticipated safety risks. The document concludes by predicting more monoclonal antibody approvals and emphasizes the need for rigorous evaluation of safety, efficacy and cost-effectiveness as with other medical therapies.
This document summarizes various approaches for managing type 1 diabetes, including the bionic pancreas, islet transplantation, and stem cell therapy. It notes that the bionic pancreas can help improve glucose control but has limitations like being invasive and not physiological. Islet transplantation via the Edmonton protocol can cure diabetes, but challenges remain in expanding the donor supply and improving techniques. Stem cell therapy shows promise if stem cells can be encapsulated to both differentiate into insulin-producing cells and avoid immune rejection. Overall, a cure exists on the horizon, but further progress is still needed to overcome immune issues and increase donor availability.
HFPEF is defined as clinical signs of congestive heart failure with a preserved left ventricular ejection fraction over 50%. It accounts for about half of all heart failure cases and is associated with significant mortality. The pathophysiology involves abnormal ventricular stiffness from an upward and leftward shift in the end diastolic pressure-volume relationship. This results in poor exercise tolerance and fatigue. While the exact causes are unclear, comorbidities like hypertension, diabetes and obesity likely play a key role. No treatments shown to improve outcomes for heart failure with reduced ejection fraction have been effective for HFPEF.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Noon conference: Intro to Toxicology
1. IM BoardIM Board
Prep FunPrep Fun
ToxicologyToxicology
Kurt Kleinschmidt, MD,Kurt Kleinschmidt, MD,
FACEP, FACMTFACEP, FACMT
Professor ofProfessor of
Emergency MedicineEmergency Medicine
Division Chief &Division Chief &
Program DirectorProgram Director
Medical ToxicologyMedical Toxicology
UTSW Medical CenterUTSW Medical Center
2. • Drug overdoseDrug overdose
• Hazardous exposure to chemical productsHazardous exposure to chemical products
– Pesticides; heavy metalsPesticides; heavy metals
– Household productsHousehold products
– Toxic gasesToxic gases
– Toxic alcoholsToxic alcohols
– Other industrial chemicalsOther industrial chemicals
• Drug Abuse management & MRODrug Abuse management & MRO
• EnvenomationsEnvenomations
• Food-borne toxins, such as botulism; marine toxinsFood-borne toxins, such as botulism; marine toxins
(e.g. paralytic shellfish toxin; ciguatoxin).(e.g. paralytic shellfish toxin; ciguatoxin).
• Plants and mushrooms.Plants and mushrooms.
• Independent medical examinationsIndependent medical examinations
Problems Evaluated By ToxicologistsProblems Evaluated By Toxicologists
3. Board CertificationBoard Certification
• American Board Medical Specialties RecognizedAmerican Board Medical Specialties Recognized
• First ABMS exam 2000First ABMS exam 2000
• Toxicology is a Dependent “Sub-Board”Toxicology is a Dependent “Sub-Board”
– Emergency Medicine (Administrative)Emergency Medicine (Administrative)
– Preventive MedicinePreventive Medicine
– PediatricsPediatrics
• Approximately 50 examinees everyApproximately 50 examinees every otherother yearyear
• Total Boarded < 400Total Boarded < 400
4. Which physicians can becomeWhich physicians can become
medical toxicologists?medical toxicologists?
• Emergency MedicineEmergency Medicine
• Preventive andPreventive and
Occupational MedicineOccupational Medicine
• PediatricsPediatrics
• Internal MedicineInternal Medicine
• Family MedicineFamily Medicine
• PsychiatryPsychiatry
• NeurologyNeurology
> 50%> 50%
> 95%> 95%
5. North Texas Poison CenterNorth Texas Poison Center
Division of Toxicology ≠ Poison Center
(But we do share much)
6. ToxidromesToxidromes
• Collection of symptoms characteristic forCollection of symptoms characteristic for
specific agent groupsspecific agent groups
• Many different agents can cause “a”Many different agents can cause “a”
toxidrometoxidrome
• Management of any one toxidrome…Management of any one toxidrome…
– Is the sameIs the same
– No matter the agentNo matter the agent
7. ToxidromesToxidromes
SympathomimeticSympathomimetic Cocaine, Amphetamines,Cocaine, Amphetamines,
Decongestants, CaffeineDecongestants, Caffeine
AnticholinergicAnticholinergic 11stst
-Generation antihistamines,-Generation antihistamines,
Neuroleptics, TricyclicsNeuroleptics, Tricyclics
CholinergicCholinergic Carbamates,Carbamates,
OrganophosphatesOrganophosphates
OpioidOpioid Codeine, Morphine,Codeine, Morphine,
HydrocodoneHydrocodone
Sedative-HypnoticSedative-Hypnotic Benzos, Barbs, EthanolBenzos, Barbs, Ethanol
SerotonergicSerotonergic Too many to list…Too many to list…
8. Adrenal
Medulla
EpiEpi NENE
NN
VasoconstrictionVasoconstriction
↑↑ UrethralUrethral
Sphincter ToneSphincter Tone
MydriasisMydriasis
DiaphoresisDiaphoresis MM
αα
TachycardiaTachycardia
VasodilationVasodilation
BronchodilationBronchodilation
MetabolicMetabolic
↓↓ K+K+
↓↓ PO4PO4
↓↓ pHpH
↑↑ GlucoseGlucose
↑↑ WBCWBC
ββ
NENE
NENE
NN
NN
AChACh DDiarrheaiarrhea
UUrinationrination
MMiosisiosis
BBronchospasmronchospasm
BBronchorrhearonchorrhea
EEmesismesis
LLacrimationacrimation
SSalivationalivation
NN
MM
AChACh
AChACh
AChACh
AChACh
AChACh
ANSANS
ParsympatheticParsympatheticSympatheticSympathetic
9. AnticholinergicsAnticholinergics
Hot as a hareHot as a hare HyperthermiaHyperthermia
Mad as a hatterMad as a hatter Delirium / AgitationDelirium / Agitation
Dry as a boneDry as a bone Skin; Muc Membranes DrySkin; Muc Membranes Dry
Red as a beetRed as a beet Skin flushedSkin flushed
TachycardiaTachycardia
Hypoactive Bowel SoundsHypoactive Bowel Sounds
Bladder Urine RetentionBladder Urine Retention
But which are
the most
Sensitive?
10. Anticholinergic vs. SympathomimeticAnticholinergic vs. Sympathomimetic
SympathoSympatho Anti-CholAnti-Chol
HRHR ↑ ↑↑ ↑
BPBP ↑ ↑↑ ↑
PupilsPupils ↑ ↑↑ ↑
MentalMental AgitatedAgitated AgitatedAgitated
BladderBladder NmlNml Nml orNml or ↑↑
Bowel SoundsBowel Sounds NmlNml Nml orNml or ↓↓
SkinSkin WetWet Dry**Dry**
12. OpioidOpioid
The ToxidromeThe Toxidrome
• Mental status depressedMental status depressed
• MiosisMiosis
• Respirations depressedRespirations depressed
Not always clear…Coingestants…Not always clear…Coingestants…
Hypoxic Brain damage may already be presentHypoxic Brain damage may already be present
Narcan is a poor diagnostic toolNarcan is a poor diagnostic tool
15. 6 Acetaminophen Cases6 Acetaminophen Cases
All are 40 y/o Males who took 15 grams…All are 40 y/o Males who took 15 grams…
• 2 hrs before arrival2 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 8 hrs before arrival8 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 15 hrs before arrival15 hrs before arrival
– One vomitingOne vomiting
– One notOne not
Start antidote before getting a level?Start antidote before getting a level?
PO or IV?PO or IV?
Duration of therapy?Duration of therapy?
Role of repeat levels?Role of repeat levels?
16. Acetaminophen Case ContinuedAcetaminophen Case Continued
• 2 hrs before arrival2 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 8 hrs before arrival8 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 15 hrs before arrival15 hrs before arrival
– One vomitingOne vomiting
– One notOne not
Start antidote before getting a level?
No
PO or IV?
If toxic level, go IV
Duration of therapy?
If IV, Bolus + 20 hours
Role of repeat levels?
None
Start antidote before getting a level?Start antidote before getting a level?
PO or IV?PO or IV?
Duration of therapy?Duration of therapy?
Role of repeat levels?Role of repeat levels?
17. Acetaminophen Case ContinuedAcetaminophen Case Continued
• 2 hrs before arrival2 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 8 hrs before arrival8 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 15 hrs before arrival15 hrs before arrival
– One vomitingOne vomiting
– One notOne not
Start antidote before getting a level?
Yes
PO or IV?
If Vomiting, go IV
If Not Vomiting, go PO (?)
Duration of therapy?
If IV, Bolus + 20 hours
If PO, typically 24-36 hrs
Role of repeat levels?
None
Start antidote before getting a level?Start antidote before getting a level?
PO or IV?PO or IV?
Duration of therapy?Duration of therapy?
Role of repeat levels?Role of repeat levels?
18. • If treated within 8 hrsIf treated within 8 hrs
– No pts → Liver FailureNo pts → Liver Failure
– Some patients → HepatitisSome patients → Hepatitis
• Toxicity Defined – AST > 1000Toxicity Defined – AST > 1000
19. Acetaminophen Case ContinuedAcetaminophen Case Continued
• 2 hrs before arrival2 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 8 hrs before arrival8 hrs before arrival
– One vomitingOne vomiting
– One notOne not
• 15 hrs before arrival15 hrs before arrival
– One vomitingOne vomiting
– One notOne not
Start antidote before getting a level?
Yes (?)
PO or IV?
If Vomiting, go IV
If Not Vomiting, go PO (?)
Duration of therapy?
If IV, typically 36 hrs**
If PO, typically 36 hrs
Role of repeat levels?
None
Start antidote before getting a level?Start antidote before getting a level?
PO or IV?PO or IV?
Duration of therapy?Duration of therapy?
Role of repeat levels?Role of repeat levels?
Duration based upon LFTs.
Note that Acetadote use is likely BEYOND 21 hours
20. Besides vomiting, conditionsBesides vomiting, conditions
where IV route is preferred?where IV route is preferred?
PregnancyPregnancy
Liver FailureLiver Failure
Lets talk…BioavailabilityLets talk…Bioavailability
21. LithiumLithium
• Your body thinks it is sodium…and treats it as suchYour body thinks it is sodium…and treats it as such
• ClinicalClinical
– NeuromuscularNeuromuscular – tremor; ↑ DTRs (very sensitive)– tremor; ↑ DTRs (very sensitive)
– Chronic Neuro Sequelae #1 Concern.Chronic Neuro Sequelae #1 Concern.
• Include cerebellar issues; memory deficits, NM weak, personalityInclude cerebellar issues; memory deficits, NM weak, personality
change, tremors.change, tremors.
• DecontaminationDecontamination
– Charcoal – No role (like all monovalent cations)Charcoal – No role (like all monovalent cations)
– Whole Bowel IrrigationWhole Bowel Irrigation
• Fluids and Electrolytes - Key - Restore volume if there is depletion,Fluids and Electrolytes - Key - Restore volume if there is depletion,
otherwise Lithium elimination is slowedotherwise Lithium elimination is slowed
• Dialysis -Dialysis - Ideal for dialysis - (1) small, (2) not protein bound, and (3) smallIdeal for dialysis - (1) small, (2) not protein bound, and (3) small
volume of distributionvolume of distribution; BUT…Li; BUT…Li++
is mainly intracellular and it diffuses slowlyis mainly intracellular and it diffuses slowly
across cell membranes (needs serial HD treatments)across cell membranes (needs serial HD treatments)
– Indication - Severe neurotoxicity i.e. AMS, those with ARF, Level > 4.0Indication - Severe neurotoxicity i.e. AMS, those with ARF, Level > 4.0
mEq/L (Acute) or 2.5 mEq/L (Chronic).mEq/L (Acute) or 2.5 mEq/L (Chronic).
22. Distribution Clinical MomentsDistribution Clinical Moments
LithiumLithium
• Normal Level: 0.6-1.2 mEq/LNormal Level: 0.6-1.2 mEq/L
• Which is clinically worse for a patient?Which is clinically worse for a patient?
– Level 4.2 mEq/LLevel 4.2 mEq/L
– Level 2.2 mEq/LLevel 2.2 mEq/L
It all depends…It all depends…
Acute vs Chronic ExposureAcute vs Chronic Exposure
Agent with slow distributionAgent with slow distribution
23. Distribution Clinical MomentsDistribution Clinical Moments
- Lithium- Lithium
FastFast
SlowSlow
Stomach and IntestinesStomach and Intestines
Blood andBlood and
some organs (Liver)some organs (Liver)
BrainBrain
AcuteAcute ChronicChronic
4.24.2 2.22.2
0.20.2 2.22.2
AbsorptionAbsorption
DistributionDistribution
25. Clinical Signs and SymptomsClinical Signs and Symptoms
Salicylate Toxidrome (Acute)Salicylate Toxidrome (Acute)
• Shortness of Breath (Hyperpnea, Tachypnea)Shortness of Breath (Hyperpnea, Tachypnea)
• N/V & stomach upsetN/V & stomach upset
• Tinnitus and/or Hearing changeTinnitus and/or Hearing change
• DizzyDizzy
• DiaphoresisDiaphoresis
My great clinical moment…My great clinical moment…
Can be easy to miss
26. More Clinical Signs and SymptomsMore Clinical Signs and Symptoms
• CNSCNS
– AMS (Cerebral edema, Hypoglycemia)AMS (Cerebral edema, Hypoglycemia)
– SeizuresSeizures
• HyperthermiaHyperthermia
• Non-Cardiogenic Pulmonary EdemaNon-Cardiogenic Pulmonary Edema
• Metabolic Acidosis & Resp AlkalosisMetabolic Acidosis & Resp Alkalosis
• CoagulopathyCoagulopathy
• Liver failureLiver failure
• Renal failureRenal failure
Multiorgan!Multiorgan!
Often confused with SepsisOften confused with Sepsis
and/or other conditionsand/or other conditions
27. LaboratoryLaboratory
• Anion-Gap Metabolic AcidosisAnion-Gap Metabolic Acidosis
• Plasma Salicylate LevelsPlasma Salicylate Levels
– Serial levelsSerial levels
– Useless without clinical courseUseless without clinical course
29. TreatmentTreatment
• Absorption:Absorption: CharcoalCharcoal → ↓→ ↓ AbsorptionAbsorption
• Distribution:Distribution: Not a targetNot a target
• Metabolism and EliminationMetabolism and Elimination
– Multidose Activated CharcoalMultidose Activated Charcoal
– Ion Trapping (Sodium Bicarbonate)Ion Trapping (Sodium Bicarbonate)
– HemodialysisHemodialysis
30. Ion TrappingIon Trapping
Brain Blood
Renal
Tubule
HAHA
↑ ↓↑ ↓
HH++
+ A+ A--
Diurese it outDiurese it out
HAHA
↑ ↓↑ ↓
HH++
+ A+ A--
HAHA
↑ ↓↑ ↓
HH++
+ A+ A--
31. Ion TrappingIon Trapping
Brain Blood
Renal
Tubule
HAHA
↑↑ ↓↓
HH++
+ A+ A--
Diurese it outDiurese it out
HAHA
↑↑ ↓↓
HH++
+ A+ A--
HAHA
↑↑ ↓↓
HH++
+ A+ A--
A weak acid in an alkaline environmentA weak acid in an alkaline environment
Alkalinize the urineAlkalinize the urine
32. HemodialysisHemodialysis
Items amendable to dialysisItems amendable to dialysis
• SmallSmall
• Non-chargedNon-charged
• Low Volume of DistributionLow Volume of Distribution
(Agent mostly in the blood)(Agent mostly in the blood)
Indications with SalicylatesIndications with Salicylates
• Renal failure (the # 1 indication)Renal failure (the # 1 indication)
• Metabolic acidosis (persistent)Metabolic acidosis (persistent)
• Cerebral or Pulmonary edemaCerebral or Pulmonary edema
• Really nasty, horrid, ugly high levelsReally nasty, horrid, ugly high levels
33. Pitfalls in Salicylate ManagementPitfalls in Salicylate Management
• Failure to be scaredFailure to be scared
• Failure to know that symptomsFailure to know that symptoms
can be delayedcan be delayed
• Ruling out toxicity usingRuling out toxicity using
serum level aloneserum level alone
• Failure to alkalinize the urine dueFailure to alkalinize the urine due
to inadequate K+ levelto inadequate K+ level
• Failure to Dialyze in the reallyFailure to Dialyze in the really
sick ones!!!!!!!!!!!!!!!!!!!!!!!!!sick ones!!!!!!!!!!!!!!!!!!!!!!!!!
Continue therapy untilContinue therapy until
symptoms are gonesymptoms are gone
• Sodium BicarbSodium Bicarb
for Ion Trappingfor Ion Trapping
• Multiple DoseMultiple Dose
ActivatedActivated
CharcoalCharcoal
34. CyanideCyanide
• Cyanide Salts: IngestCyanide Salts: Ingest →→ CN-salt + stomach AcidCN-salt + stomach Acid →→
HCNHCN →→ AbsorbedAbsorbed →→ DieDie
• HCN Gas:HCN Gas: InhaleInhale →→ Mucosal absorptionMucosal absorption →→ DieDie
Burn...Burn...
Plastics (Polyacrylonitriles, Polyacrylamides)Plastics (Polyacrylonitriles, Polyacrylamides)
Foam (Polyurethane)Foam (Polyurethane)
Varnishes and Paints (Polyurethane)Varnishes and Paints (Polyurethane)
Wool and SilkWool and Silk
FireFire
SmokeSmoke
withwith
HCNHCN
Formed when combine an acid with
the salt; thus keep pH high, no gas
will be created
35. Cyanide PathophysiologyCyanide Pathophysiology
Binds ferric ion inBinds ferric ion in
CytochromeCytochrome
OxidaseOxidase
CNCN
Cyt a3++Cyt a3++Cyt a3+++Cyt a3+++
OO22 2H2H22OO
OxidativeOxidative
PhosphorylationPhosphorylation
X
X
Can NOT use OCan NOT use O22
CNSCNS
LOCLOC
SeizuresSeizures
Body IschemiaBody Ischemia
Severe Met acidosisSevere Met acidosis
39. NitritesNitrites
Side EffectsSide Effects
– VasodilationVasodilation →→ HypotensionHypotension
– MethemoglobinemiaMethemoglobinemia →→ ↓↓OO22 Carrying CapacityCarrying Capacity
• Create a “toxicity” to cure another “toxicity”Create a “toxicity” to cure another “toxicity”
• Another issue in smoke inhalation settingAnother issue in smoke inhalation setting
Carbon Monoxide alsoCarbon Monoxide also
→→ “Dys-hemoglobinemia”“Dys-hemoglobinemia”
→→ ↓↓OO22 Carrying CapacityCarrying Capacity
Sodium ThiosulfateSodium Thiosulfate
is quite benignis quite benign
Normal
Hemoglobin
42. Alcohols that in significant amountsAlcohols that in significant amounts
typically cause specific end organtypically cause specific end organ
damage if not managed appropriatelydamage if not managed appropriately
Toxic AlcoholsToxic Alcohols
DefinedDefined
These include:These include:
• Ethylene GlycolEthylene Glycol
• MethanolMethanol
Do NOT include:Do NOT include:
• IsopropanolIsopropanol
• EthanolEthanol
48. ManagementManagement
HemodialysisHemodialysis
• SymptomaticSymptomatic
• Significant metabolic acidosis (?)Significant metabolic acidosis (?)
– pH < 7.1pH < 7.1
– One that can’t easily correctOne that can’t easily correct
• Ethylene glycol or methanol levelsEthylene glycol or methanol levels
– > 25 mg/dL> 25 mg/dL
– > 50 mg/dL> 50 mg/dL
• Renal compromiseRenal compromise
?
Indications:
Symptoms
present
Often doneOften done
after symptomsafter symptoms
have begunhave begun
49. Sodium BicarbonateSodium Bicarbonate
For TCAs and OtherFor TCAs and Other
Sodium Channel BlockersSodium Channel Blockers
•It’s theIt’s the sodiumsodium that countsthat counts
•Boluses (Boli?) – the way to goBoluses (Boli?) – the way to go
•You follow your “efficacy” thru – QRS!!!You follow your “efficacy” thru – QRS!!!
•QRS corrects rapidly (minutes)QRS corrects rapidly (minutes)
50. • The big questions – Is there a correlation between…The big questions – Is there a correlation between…
– QRS ≥ 100 ms & TCA concentration > 1000 ng/mLQRS ≥ 100 ms & TCA concentration > 1000 ng/mL
– Development of seizures orDevelopment of seizures or
ventricular dysrhythmias andventricular dysrhythmias and
• QRS ≥ 100 msQRS ≥ 100 ms
• TCA concentration > 1000 ng/mLTCA concentration > 1000 ng/mL
NEJM 1985
313:474-9
51. Figure 1Figure 1
Correlation between theCorrelation between the
max Limb Lead QRSmax Limb Lead QRS
Duration and theDuration and the
Occurrence of Seizures ofOccurrence of Seizures of
Ventricular Arrhythmias.Ventricular Arrhythmias.
Each circle denotes 1 of theEach circle denotes 1 of the
49 study patients.49 study patients.
52. Vs. Sodium BicarbonateVs. Sodium Bicarbonate
with Salicylateswith Salicylates
• It’s the bicarbonate that countsIt’s the bicarbonate that counts
• Done as an infusion.Done as an infusion.
• You will cause hypokalemiaYou will cause hypokalemia
• You monitor “efficacy” via – urine pHYou monitor “efficacy” via – urine pH
(want it high to trap)(want it high to trap)